fbpx
June 9, 2022

Novel Drug Safe, Effective in Relapsing MS: 2-Year Data Novel Drug Safe, Effective in Relapsing MS: 2-Year Data

NATIONAL HARBOR, Maryland — Evobrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor for relapsing multiple sclerosis (RMS), is relatively safe and effective over the long-term, new […]
June 9, 2022

‘Genetic’ Height Linked to Peripheral Neuropathy, Other Disorders ‘Genetic’ Height Linked to Peripheral Neuropathy, Other Disorders

A person’s ‘genetic’ height – the height they are predicted to reach independent of environmental influences – may be an underappreciated risk factor for a wide […]
June 9, 2022

General Neurologists’ MS Knowledge Falls Short General Neurologists’ MS Knowledge Falls Short

NATIONAL HARBOR, MD — As multiple sclerosis (MS) therapies expand and therapeutic decision-making becomes more complex, new research shows that general neurologists fall far below MS […]
June 9, 2022

Profound Neuroinflammation Tied to Long COVID Pathophysiology Profound Neuroinflammation Tied to Long COVID Pathophysiology

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The study covered in this summary was published on medRxiv.org as a […]
June 8, 2022

Social Isolation in the Elderly Tied to Increased Dementia Risk Social Isolation in the Elderly Tied to Increased Dementia Risk

Social isolation is associated with a significantly increased risk of dementia in older people, new research shows. Results of a large, prospective, epidemiologic study show that […]
June 7, 2022

‘Alarming’ New Data on Disordered Sleep After COVID ‘Alarming’ New Data on Disordered Sleep After COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Moderate to severe sleep disturbances and severe fatigue affect up to 40% […]
June 7, 2022

A Better Predictor of Atrial Fibrillation? A Better Predictor of Atrial Fibrillation?

Sleep-related hypoxemia is a better indicator of atrial fibrillation (AF) risk than the commonly-used apnea-hypopnea index (AHI), new research suggests. “Our findings suggest the importance of […]
June 7, 2022

Two Promising Bridge Therapies for Medication Overuse Headaches Two Promising Bridge Therapies for Medication Overuse Headaches

This study was published as a preprint and has not yet been peer reviewed. Key Takeaway Among patients with MOH of longer duration, response to treatment […]
June 7, 2022

Non-White MS Patients Rarely Included in Trials Non-White MS Patients Rarely Included in Trials

NATIONAL HARBOR, Maryland — Over 25 years of clinical research, phase 3 trials of approved disease-modifying therapies (DMTs) for multiple sclerosis (MS) were overwhelmingly made up of […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0